The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.15 million shares were traded. ENFN stock price reached its highest trading level at $11.125 during the session, while it also had its lowest trading level at $11.06.
Ratios:
To gain a deeper understanding of ENFN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.14. For the most recent quarter (mrq), Quick Ratio is recorded 3.42 and its Current Ratio is at 3.42. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.19.
On February 28, 2024, Goldman Downgraded its rating to Sell which previously was Neutral and also lowered its target price recommendation from $9 to $8.
JP Morgan Downgraded its Neutral to Underweight on January 30, 2024, whereas the target price for the stock was revised from $11 to $9.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 05 ’25 when Bastone Bronwen sold 3,126 shares for $11.38 per share. The transaction valued at 35,558 led to the insider holds 221,875 shares of the business.
Campobasso Matthew sold 1,695 shares of ENFN for $19,281 on Mar 05 ’25. The General Counsel now owns 70,946 shares after completing the transaction at $11.38 per share. On Mar 06 ’25, another insider, Movchan Oleg, who serves as the Chief Executive Officer of the company, sold 11,452 shares for $11.39 each. As a result, the insider received 130,473 and left with 631,847 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENFN now has a Market Capitalization of 1051355264 and an Enterprise Value of 1044642624. As of this moment, Enfusion’s Price-to-Earnings (P/E) ratio for their current fiscal year is 543.63, and their Forward P/E ratio for the next fiscal year is 29.84. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 20.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.10 while its Price-to-Book (P/B) ratio in mrq is 14.34. Its current Enterprise Value per Revenue stands at 5.181 whereas that against EBITDA is 82.197.
Stock Price History:
The Beta on a monthly basis for ENFN is 0.93, which has changed by 0.19504309 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, ENFN has reached a high of $11.80, while it has fallen to a 52-week low of $7.83. The 50-Day Moving Average of the stock is 0.04%, while the 200-Day Moving Average is calculated to be 15.69%.
Shares Statistics:
It appears that ENFN traded 1.05M shares on average per day over the past three months and 954090 shares per day over the past ten days. A total of 94.66M shares are outstanding, with a floating share count of 48.88M. Insiders hold about 48.44% of the company’s shares, while institutions hold 44.70% stake in the company. Shares short for ENFN as of 1740700800 were 948035 with a Short Ratio of 0.90, compared to 1738281600 on 1010412. Therefore, it implies a Short% of Shares Outstanding of 948035 and a Short% of Float of 2.0599999.
